The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 02, 2019
Filed:
Dec. 22, 2015
Applicant:
Galderma Research & Development, Biot, FR;
Inventors:
Jean-Francois Fournier, Juan les Pins, FR;
Laurence Clary, La Colle sur Loup, FR;
Etienne Thoreau, Saint Vallier de Thiey, FR;
Assignee:
GALDERMA RESEARCH & DEVELOPMENT, Biot, FR;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 239/10 (2006.01); C07D 401/14 (2006.01); C07D 413/14 (2006.01); C07D 401/06 (2006.01); C07D 403/06 (2006.01); C07D 407/14 (2006.01); C07D 409/14 (2006.01); C07D 471/04 (2006.01); C07D 498/20 (2006.01); C07D 211/36 (2006.01); C07D 239/80 (2006.01); C07D 245/06 (2006.01); C07D 403/14 (2006.01); A61K 31/499 (2006.01); A61P 25/06 (2006.01); A61P 17/06 (2006.01);
U.S. Cl.
CPC ...
C07D 239/10 (2013.01); C07D 211/36 (2013.01); C07D 239/80 (2013.01); C07D 245/06 (2013.01); C07D 401/06 (2013.01); C07D 401/14 (2013.01); C07D 403/06 (2013.01); C07D 403/14 (2013.01); C07D 407/14 (2013.01); C07D 409/14 (2013.01); C07D 413/14 (2013.01); C07D 471/04 (2013.01); C07D 498/20 (2013.01);
Abstract
The invention relates to novel heterocyclic compounds of general formula (I), as well as their pharmaceutically acceptable salts, and their enantiomers. The invention also relates to the use thereof as a medicinal product, preferably in the prevention and/or treatment of inflammatory diseases with a neurogenic component or use thereof as a cosmetic. The compounds of the present invention act as antagonists of the CGRP-R receptor.